Rossella De Cecio Selected Research

Angiogenesis Inhibitors

1/2020

Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rossella De Cecio Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 01/2009
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 02/2017
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 07/2020
2	Disease Progression 01/2023 - 01/2022
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022 - 03/2022
2	Ovarian Neoplasms (Ovarian Cancer) 10/2021 - 01/2020
2	Lung Neoplasms (Lung Cancer) 07/2020 - 01/2020
2	Squamous Cell Carcinoma of Head and Neck 01/2020 - 11/2016
1	Endometrial Neoplasms (Endometrial Cancer) 01/2023
1	Adenocarcinoma 03/2022
1	Adenocarcinoma of Lung 01/2022
1	Circulating Neoplastic Cells 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020
1	Hemorrhage 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 07/2019
1	Carcinogenesis 05/2019
1	Breast Neoplasms (Breast Cancer) 02/2017
1	Triple Negative Breast Neoplasms 02/2017
1	Hemangiosarcoma (Angiosarcoma) 01/2017

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2017
4	B7-H1 AntigenIBA 01/2020 - 05/2016
3	AntibodiesIBA 02/2017 - 05/2016
2	domatinostatIBA 04/2022 - 03/2022
2	Cell-Free Nucleic AcidsIBA 01/2022 - 12/2020
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022 - 01/2020
2	Bevacizumab (Avastin)FDA Link 10/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 02/2017
2	Cetuximab (Erbitux)FDA Link 01/2020 - 11/2016
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 11/2016
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2020 - 11/2016
1	avelumabIBA 01/2023
1	Carboplatin (JM8)FDA LinkGeneric 01/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2023
1	TrabectedinIBA 01/2022
1	PM 01183IBA 01/2022
1	Untranslated RNA (Noncoding RNA)IBA 02/2021
1	HMGA ProteinsIBA 01/2021
1	PlatinumIBA 09/2020
1	NivolumabIBA 09/2020
1	pembrolizumabIBA 09/2020
1	Messenger RNA (mRNA)IBA 07/2020
1	atezolizumabIBA 07/2020
1	Monoclonal AntibodiesIBA 07/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2020
1	RamucirumabIBA 01/2020
1	ParaffinIBA 01/2020
1	Generic DrugsIBA 01/2020
1	Angiogenesis InhibitorsIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	Integrin alphaVIBA 07/2019
1	IntegrinsIBA 07/2019
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2018
1	Androgen Receptors (Androgen Receptor)IBA 01/2018
1	Estrogen Receptor alphaIBA 01/2018
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 02/2017
1	DNA (Deoxyribonucleic Acid)IBA 02/2017
1	Fluorouracil (Carac)FDA LinkGeneric 11/2016

Therapy/Procedure

8	Therapeutics 01/2023 - 01/2017
5	Drug Therapy (Chemotherapy) 01/2023 - 11/2016
3	Immunotherapy 01/2023 - 01/2017
1	Intravenous Infusions 01/2020
1	Biological Therapy 01/2018
1	Oral Surgical Procedures 07/2016
1	Radiotherapy 01/2009